Home > Financial Ratios > HALEOS LABS

HALEOS LABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HALEOS LABS
Please provide your vote to see the results

HALEOS LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -5.5042.549.88-12.0713.25

What is the latest Core EBITDA Growth ratio of HALEOS LABS ?

The latest Core EBITDA Growth ratio of HALEOS LABS is -5.50 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-5.50
Mar202542.54
Mar20249.88
Mar2023-12.07
Mar202213.25

How is Core EBITDA Growth of HALEOS LABS Trending?

Years Core EBITDA Growth % Change
Mar2026 -5.5
Negative
Mar2025 42.54
330.57
Mar2024 9.88
Positive
Mar2023 -12.07
Negative
Mar2022 13.25 -

Other Financial Ratios of HALEOS LABS


Compare Core EBITDA Growth ratio of peers of HALEOS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HALEOS LABS ₹407.8 Cr -12.8% -7.5% 28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


HALEOS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HALEOS LABS

-12.8%

-7.5%

28.4%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses